Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New hope for bladder cancer patients: drug may help avoid bladder removal

NCT ID NCT03697850

First seen Nov 18, 2025 · Last updated May 20, 2026 · Updated 24 times

Summary

This study is for people with muscle-invasive bladder cancer who cannot have their bladder removed due to age, health issues, or personal choice. After standard chemo-radiation, participants receive the drug atezolizumab to help keep the cancer from coming back. The goal is to control the disease and preserve the bladder.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Centre Antoine Lacassagne

    Nice, France

  • Centre Azureen de Cancerologie

    Mougins, 06250, France

  • Centre Georges Francois Leclerc

    Dijon, France

  • Centre Jean Perrin

    Clermont-Ferrand, France

  • Centre Oscar Lambret

    Lille, France

  • Chu Lyon Sud

    Pierre-Bénite, France

  • Gustave Roussy

    Villejuif, 94800, France

  • Hopital Saint Louis

    Paris, France

  • Hôpital Pitie Salpetriere

    Paris, France

  • INSTITUT de CANCEROLOGIE DE L'OUEST - site René Gauducheau

    Saint-Herblain, France

  • Icm Val D'Aurelle

    Montpellier, France

  • Institut Bergonie

    Bordeaux, France

Conditions

Explore the condition pages connected to this study.